Clinical trial
3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in…
NCT00222872 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00222872 |
|---|---|
| Title | 3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal Women |
| Official title | A Three Week Dose Escalation Study of PTHrP(1-36) in Postmenopausal Women |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Institutes of Health (NIH) NIH Department of Health and Human Services U.S. Fed |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Osteoporosis, Postmenopausal |
| Intervention type | Drug |
| Interventions | Parathyroid Hormone-related Protein, Placebo |
| Enrollment | 61 |
| Start date | Jul 1, 2005 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Sep 22, 2005 |
| Last update posted | Apr 28, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: